Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3034099	li-cmvab	— (—)	73	77	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Polyneuropathies and other disorders of the peripheral nervous system

15.02

16.75

1.0

—

Fever of other and unknown origin

8.47

15.78

1.0

1.1

—

ILD medications: immunosuppressive drugs

7.12

15.25

1.0

—

Pneumonia, organism unspecified

6.14

14.46

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5.70

14.29

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

5.62

14.02

1.0

1.1

—

Bacterial infection, other or unspecified

7.85

13.99

1.1

—

All pneumoniae

5.31

13.26

1.0

1.1

—

Influenza and pneumonia

5.23

13.21

1.0

1.1

—

Oral corticosteroids

5.21

12.71

1.0

1.1

—

Visual disturbances and blindness

6.56

11.90

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.14

11.77

1.1

—

Other bacterial diseases

5.19

11.68

1.0

1.1

—

Inflammatory bowel disease treatment related agents

4.66

11.41

1.0

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.43

11.29

1.0

1.1

—

5.43

11.29

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

10.91

11.05

1.0

—

Autoimmune diseases excluding thyroid diseases

4.88

10.74

1.0

1.1

—

ILD medications

4.71

10.66

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

4.85

9.98

1.0

1.1

—

L04AX Other immunosuppressants

5.14

9.34

1.0

1.1

—

Second line medication for Crohn's disease

5.14

9.34

1.0

1.1

—

Visual disturbances

6.25

8.98

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.89

8.64

1.0

1.1

—

Oedema, not elsewhere classified

9.95

8.59

1.1

1.0

—

Epilepsy

8.44

8.43

1.0

—

Diagnoses used for exclusion with ILD

9.10

8.08

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.00

7.92

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

15.01

7.70

1.0

—

Disorders of lens

4.99

7.66

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.91

7.65

1.0

1.1

—

Other disorders of lacrimal gland

7.34

7.55

1.0

1.1

—

Autoimmune diseases related-to ILD

4.02

7.45

1.0

1.1

—

Disorders of lacrimal system

6.32

7.24

1.0

1.1

—

Implicit viral Sepsis

20.02

7.13

1.1

1.0

—

Viral Sepsis

20.02

7.13

1.1

1.0

—

Low back pain

4.30

7.04

1.1

—

Other and unspecified polyneuropathies, also in other diseases

13.77

6.88

1.0

—

Other septicaemia

5.89

6.73

1.1

1.0

—

Symptoms and signs involving speech and voice

7.15

6.69

1.0

1.1

—

Explicit Sepsis

5.42

6.67

1.1

1.0

—

Other symptoms and signs involving cognitive functions and awareness

5.93

6.66

1.1

—

Certain infectious and parasitic diseases

4.76

6.61

1.1

—

General symptoms and signs

3.97

6.60

1.0

1.1

—

Septicaemia

5.77

6.55

1.1

1.0

—

Senile cataract

4.79

6.54

1.1

—

Bacterial pneumoniae

7.38

6.54

1.0

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

18.03

6.26

1.0

—

Other neurological diseases

4.02

6.24

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

3.73

5.93

1.1

—

Neurological diseases

5.87

5.90

1.1

—

Persons encountering health services for specific procedures and health care

3.39

5.86

1.1

1.0

—

Cerebrovascular diseases (FINNGEN)

7.16

5.81

1.2

1.1

—

Diabetes, varying definitions

3.46

5.69

1.0

1.1

—

Diabetes mellitus

3.45

5.68

1.0

1.1

—

Type 2 diabetes, wide definition

3.91

5.63

1.0

1.1

—

First line medication for Crohn's disease

3.43

5.45

1.0

1.1

—

Implicit bacterial Sepsis

5.31

5.43

1.1

1.0

—

4.76

5.42

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

16.02

5.41

1.0

—

Headache

4.33

5.39

1.0

1.1

—

Autoimmune diseases

3.40

5.27

1.0

1.1

—

COPD/asthma/ILD related infections

3.51

5.20

1.0

1.1

—

COPD/asthma related infections

3.51

5.20

1.0

1.1

—

Care involving use of rehabilitation procedures

3.85

5.18

1.1

1.0

—

Cerebrovascular diseases

3.69

5.12

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

3.82

5.11

1.1

—

Implicit Sepsis

3.77

5.08

1.1

—

L04AA Selective immunosuppressants

10.01

5.02

1.0

—

Heart failure, not strict

3.45

4.89

1.0

1.1

—

Presence of other functional implants

4.13

4.83

1.0

1.1

—

Other cataract

5.01

4.83

1.0

1.1

—

Disorders of choroid and retina

3.36

4.80

1.1

—

Mycoses

9.01

4.78

1.0

—

Sleep disorders (combined)

3.06

4.71

1.1

1.0

—

Pure hypercholesterolaemia

3.87

4.70

1.0

1.1

—

Type 2 diabetes

3.21

4.68

1.1

—

Sleep apnoea, including avohilmo

3.03

4.63

1.1

1.0

—

Sleep apnoea

3.08

4.60

1.1

1.0

—

Focal epilepsy

10.00

4.51

1.0

—

Other disorders of urethra and urinary system

3.63

4.49

1.1

—

Fall on same level

2.79

4.43

1.1

1.0

—

Malaise and fatigue

4.90

4.40

1.1

—

Episodal and paroxysmal disorders

3.07

4.39

1.1

—

Dorsalgia

3.09

4.31

1.1

—

Polyarthropathies

3.44

4.30

1.0

1.1

—

Certain disorders involving the immune mechanism

11.68

4.27

1.0

—

Metabolic disorders

3.19

4.26

1.1

—

Bacterial Sepsis

4.26

4.23

1.1

1.0

—

Diabetes medication

2.96

4.20

1.1

—

Abnormal findings on diagnostic imaging of lung

4.12

4.18

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.17

4.17

1.1

—

Other diseases of hard tissues of teeth

3.73

4.04

1.1

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

4.39

3.98

1.0

1.1

—

Bacterial pneumonia, not elsewhere classified

6.64

3.97

1.0

1.1

—

Reimbursement for rheumatic diseases

3.41

3.88

1.0

1.1

—

Renal tubulo-interstitial diseases

2.88

3.85

1.0

1.1

—

Other viral diseases

5.99

3.80

1.1

—

Subjective visual disturbances

8.75

3.77

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

8.75

3.77

1.0

—

Focal epilepsy, strict definition

8.75

3.77

1.0

—

Secondary uncertain malignant neoplasm

12.01

3.76

1.0

—

L04AD Calcineurin inhibitors

12.01

3.76

1.2

1.0

—

Methotrexate

12.01

3.76

1.0

—

Bacterial pneumonia (organism specified)

4.14

3.75

1.0

1.1

—

Osteopathies and chondropathies

3.56

3.75

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.33

3.75

1.2

1.1

—

Codes for special purposes

4.00

3.69

1.0

—

Provisional assignment of new diseases of uncertain etiology

4.00

3.69

1.0

—

Stroke, excluding SAH

3.45

3.65

1.1

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

11.32

3.63

1.0

—

Tramadol

3.03

3.55

1.0

1.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.96

3.55

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

2.96

3.55

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2.96

3.55

1.0

1.1

—

Dizziness and giddiness

3.16

3.54

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

10.01

3.49

1.0

—

Non-small cell lung cancer

10.01

3.49

1.0

—

Biological medication for rheuma

10.01

3.49

1.0

—

Lung diseases due to external agents

10.01

3.49

1.0

—

All influenza

10.00

3.49

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.88

3.45

1.1

—

Lower back pain or/and sciatica

2.64

3.43

1.1

—

Malignant neoplasm

2.88

3.42

1.0

1.1

—

Asthma, excluding more controls

3.76

3.37

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

7.00

3.36

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.85

3.31

1.0

1.1

—

Intracranial trauma

5.98

3.26

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

2.69

3.25

1.1

—

Other intervertebral disc disorders

2.96

3.19

1.0

1.1

—

Intestinal stricture

5.34

3.19

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.69

3.17

1.1

—

Insulin medication

3.21

3.16

1.1

—

Organic, including symptomatic, mental disorders

3.80

3.16

1.0

1.1

—

Asthma, hospital admission 2, infections

2.97

3.15

1.0

1.1

—

Asthma-related infections

2.97

3.15

1.0

1.1

—

Stroke, including SAH

3.10

3.14

1.1

—

Codeine

2.75

3.10

1.0

1.1

—

Asthma (mode)

3.47

3.09

1.0

1.1

—

Other skin changes

7.51

3.05

1.2

1.0

—

Acute and subacute iridocyclitis

7.50

3.05

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

3.13

3.04

1.0

1.1

—

Hard cardiovascular diseases

2.83

3.02

1.1

—

Allergic asthma (mode)

7.37

3.01

1.0

1.1

—

Allergic asthma (mode), excluding more controls

7.37

3.01

1.0

1.1

—

Psychiatric diseases

2.57

3.00

1.1

—

Diseases of pulp and periapical tissues

4.29

2.99

1.1

—

Other retinal disorders

3.11

2.98

1.1

—

Herpesviral [herpes simplex] infections

10.01

2.98

1.0

—

Azathioprine

10.01

2.98

1.0

—

Asthma

3.39

2.97

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

3.33

2.96

1.1

1.0

—

Hypertension, essential

2.85

2.95

1.0

1.1

—

Asthma (only as main-diagnosis)

3.49

2.95

1.0

1.1

—

Spondylopathies

2.93

1.0

1.1

—

Lung cancer and mesothelioma

7.33

2.93

1.0

—

Syncope and collapse

4.73

2.87

1.1

—

Anterior Iridocyclitis

6.67

2.86

1.0

—

Dysphagia

6.67

2.86

1.0

1.1

—

Dentinal caries

5.36

2.85

1.1

—

Convulsions, not elsewhere classified

6.58

2.84

1.0

1.1

—

Asthma-related pneumonia

4.44

2.79

1.0

—

Asthma, hospital admissions 3, pneumonia

4.44

2.79

1.0

—

Asthma-related pneumonia or sepsis

4.44

2.79

1.0

—

Used for control exclusion in common control thyroid runs

2.70

2.78

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.91

2.78

1.1

—

Chronic kidney disease

4.43

2.78

1.0

—

Osteoporosis

6.36

2.77

1.0

—

Renal failure

3.26

2.76

1.0

—

Other (not insulin) diabetes medications

2.61

2.76

1.1

—

Fentanyl

8.34

2.75

1.0

—

Other dorsopathies, not elsewhere classified

2.56

2.73

1.1

—

Sulfasalazine

5.00

2.72

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

3.03

2.72

1.1

1.0

—

Dental caries

4.95

2.70

1.1

—

STROKE

2.97

2.68

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.16

2.67

1.0

1.1

—

Type 2 diabetes, definitions combined

2.63

1.1

—

Other antidepressants

2.36

2.61

1.1

—

Persons encountering health services in other circumstances

3.60

2.57

1.0

—

Rheumatoid arthritis, including avohilmo

4.00

2.56

1.0

1.1

—

Leiomyoma of uterus

4.51

2.55

1.0

1.2

—

Symptoms and signs involving the urinary system

2.58

2.53

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.62

2.52

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

2.56

2.50

1.1

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

5.56

2.50

1.0

—

Chronic lower respiratory diseases

2.18

2.48

1.1

1.0

—

Oxycodone

3.48

2.48

1.0

1.2

—

Systemic connective tissue disorders

4.38

2.47

1.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

4.52

2.46

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.54

2.46

1.1

—

Abnormalities of breathing

2.44

1.0

1.1

—

Other functional intestinal disorders

3.43

2.44

1.0

1.1

—

Rheumatoid arthritis

3.83

2.44

1.0

1.1

—

Migraine

3.48

2.44

1.0

—

Hyperlipidaemia, other/unspecified

3.79

2.43

1.0

1.1

—

Biguanides

2.40

1.1

—

Other medical care

3.72

2.40

1.1

1.0

—

Iridocyclitis

5.00

2.40

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

5.00

2.40

1.2

1.0

—

Pulmonary embolism

5.00

2.40

1.0

—

Pulmonary heart disease

5.00

2.40

1.0

—

Acute appendicitis, with complications

6.25

2.37

1.2

1.0

—

Other viral diseases, not elsewhere classified

6.24

2.36

1.0

—

DVT of lower extremities and pulmonary embolism

3.63

2.35

1.0

—

Other diseases of urinary system

2.33

2.35

1.1

—

GASTRO-related operations

3.07

2.34

1.1

—

Any gastric operation

3.07

2.34

1.1

—

Menorrhagia

4.02

2.33

1.0

—

Asthma, unspecified (mode), excluding more controls

3.69

2.31

1.0

1.1

—

5.92

2.27

1.2

1.0

—

Pain in throat and chest

2.41

2.27

1.0

1.1

—

Other and unspecified tonsillitis

3.57

2.27

1.0

1.1

—

Covid-19 confirmed case

4.62

2.27

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

4.62

2.27

1.0

—

Conjunctivitis (acute, non atopic)

4.60

2.26

1.0

1.1

—

Intestinal infectious diseases

2.26

2.25

1.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

5.56

2.21

1.0

—

Substance use, excluding alcohol

5.56

2.21

1.2

1.1

—

Cellulitis

5.56

2.21

1.0

—

Hypertensive diseases

2.48

2.19

1.0

1.1

—

Hypertension

2.48

2.18

1.0

1.1

—

Aplastic and other anaemias

3.30

2.14

1.0

—

Other/unspecified dorsalgia

3.67

2.14

1.0

1.1

—

Codeine or tramadol medication

2.17

2.13

1.0

1.1

—

Asthma, unspecified (mode)

3.34

2.11

1.0

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

4.13

2.08

1.0

—

Parasetamol

2.81

2.07

1.0

1.2

—

Chronic periapical parodontitis

5.00

2.07

1.2

1.1

—

Blepharochalasis

5.00

2.07

1.0

1.1

—

Type 1 diabetes

4.99

2.07

1.0

—

Finngen Rheumatological endpoints

2.31

2.06

1.0

1.1

—

Acute tubulo-interstitial nephritis

2.57

2.06

1.0

1.1

—

Obesity related asthma

3.50

2.05

1.0

1.1

—

Retinal detachments and breaks

3.50

2.05

1.0

1.1

—

Cervical disc disorders

3.50

2.05

1.0

1.1

—

Hypertensive diseases (excluding secondary)

3.08

2.04

1.0

1.1

—

Other arthritis (FG)

4.00

2.04

1.0

1.2

—

Infections with a predominantly sexual mode of transmission

4.00

2.03

1.0

1.1

—

Disorders of other endocrine glands

3.44

2.02

1.0

1.1

—

4.92

2.01

1.2

1.0

—

Other diseases of intestines

2.15

2.01

1.0

1.1

—

Other and unspecified dermatitis

2.63

2.00

1.1

—

Excessive attrition of teeth

3.80

1.99

1.0

1.1

—

2.11

1.99

1.1

—

Substance abuse, excluding more controls

2.65

1.98

1.1

—

Fracture of skull and facial bones

4.55

1.94

1.0

1.1

—

Other diseases of upper respiratory tract

2.20

1.93

1.0

1.1

—

Other specified/unspecified arthritis

3.75

1.93

1.0

1.1

—

Chronic sinusitis

2.96

1.93

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

2.54

1.92

1.1

—

Infections of the skin and subcutaneous tissue

2.55

1.90

1.0

1.1

—

Other reaction to severe stress, and adjustment disorders

3.18

1.88

1.0

—

Extrapyramidal and movement disorders

3.18

1.88

1.1

1.0

—

Injuries to the head

2.05

1.86

1.0

1.1

—

Dermatitis

2.39

1.84

1.1

1.0

—

Fracture of rib(s), sternum and thoracic spine

3.53

1.83

1.0

1.1

—

Dermatitis and eczema

2.03

1.81

1.1

1.0

—

Diabetic neuropathy

4.15

1.81

1.0

1.1

—

Other and unspecified anaemias

3.08

1.81

1.0

—

Other anaemias

3.07

1.80

1.0

—

Complications of surgical and medical care, not elsewhere classified

2.11

1.80

1.1

—

Spinal stenosis

2.85

1.80

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.14

1.80

1.0

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

3.04

1.79

1.3

1.0

—

Temporomandibular joint disorders, including avohilmo

3.04

1.79

1.0

1.1

—

Cough

2.74

1.77

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.11

1.76

1.0

1.1

—

Falls/tendency to fall

2.11

1.76

1.1

—

Insulin, intermediate and long-acting

2.52

1.75

1.1

—

Spondylosis

2.74

1.75

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.33

1.74

1.0

1.1

—

Polyuria

3.85

1.71

1.0

—

Cardiac arrhythmias

2.78

1.71

1.0

—

Any mental disorder

2.03

1.71

1.1

—

Other pulmonary diagnosis

2.64

1.70

1.0

1.1

—

Bronchitis

2.02

1.70

1.1

—

Any reimbursement code in KELA

3.19

1.69

1.0

—

Nausea and vomiting

3.78

1.69

1.0

—

Injuries to the knee and lower leg

1.94

1.69

1.1

1.0

—

Nerve, nerve root and plexus disorders

2.01

1.67

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

2.51

1.66

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.18

1.62

1.0

1.2

—

Paralytic ileus and intestinal obstruction

3.57

1.61

1.0

1.1

—

Dyspnoea

2.12

1.61

1.0

1.1

—

Gingivitis and periodontal diseases

2.29

1.61

1.0

1.1

—

Asthma, including avohilmo

1.90

1.60

1.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

3.96

1.59

1.0

1.1

—

Other disorders of eyelid

2.71

1.58

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.00

1.58

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

2.69

1.57

1.0

1.1

—

Non-rheumatic valve diseases

2.54

1.56

1.0

—

Venous thromboembolism

2.43

1.53

1.0

1.1

—

Disorders of conjunctiva

2.05

1.53

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.14

1.52

1.1

—

Cardiovascular diseases

2.58

1.51

1.0

1.1

—

Other heart diseases

2.72

1.51

1.0

1.1

—

Leiomyoma of uterus

2.56

1.51

1.0

1.1

—

Allergic rhinitis

3.30

1.51

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.02

1.50

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.42

1.50

1.1

1.0

—

Deviated nasal septum

2.86

1.50

1.0

1.1

—

Persons encountering health services in other circumstances, wide

1.87

1.50

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

2.47

1.48

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.15

1.48

1.2

1.0

—

Any event in cancer register

2.08

1.48

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

2.01

1.47

1.0

1.1

—

Recurrent or chronic depression

2.89

1.46

1.2

1.1

—

Insulin, fast-acting

2.73

1.43

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.31

1.42

1.0

1.1

—

Other anxiety disorders

2.48

1.42

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

2.37

1.41

1.0

1.1

—

COPD differential diagnosis

2.37

1.41

1.0

1.1

—

ILD differential diagnosis

2.37

1.41

1.0

1.1

—

Acute bronchitis

2.67

1.40

1.0

—

Obesity and other hyperalimentation

2.17

1.35

1.0

1.1

—

Excessive, frequent and irregular menstruation

2.78

1.35

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.57

1.35

1.0

1.1

—

Antihypertensive medication - note that there are other indications

2.24

1.34

1.0

—

Acute suppurative otitis media

2.92

1.33

1.0

1.1

—

Substance abuse

2.12

1.32

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

2.44

1.31

1.0

—

Vasomotor and allergic rhinitis

2.46

1.28

1.2

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.28

1.26

1.0

—

Insulin, fast-acting or short human

2.40

1.24

1.0

—

Internal derangement of knee

2.39

1.24

1.2

1.1

—

Mental and behavioural disorders due to psychoactive substance use

2.05

1.22

1.1

1.0

—

Inflammatory bowel disease

2.63

1.21

1.0

1.1

—

Intracranial injury

2.15

1.20

1.0

1.1

—

Other acute lower respiratory infections

2.12

1.19

1.0

1.1

—

Lumbar disc prolapse

2.12

1.17

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

1.88

1.17

1.0

1.1

—

Dementia, including avohilmo

2.65

1.17

1.0

—

Diseases of oesophagus, stomach and duodenum

1.79

1.17

1.0

1.1

—

Abdominal and pelvic pain

1.85

1.16

1.0

1.1

—

Opioids

1.90

1.16

1.0

1.1

—

Glaucoma suspect

2.50

1.15

1.0

1.1

—

Degeneration of macula and posterior pole

2.40

1.14

1.1

1.0

—

Complications of medical and surgical care

1.98

1.12

1.1

—

Alcohol use disorder, ICD-based

2.33

1.12

1.0

—

Obesity due to excess calories

2.33

1.12

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.31

1.11

1.0

1.1

—

Mental and behavioural disorders due to alcohol

2.00

1.11

1.0

—

Hypothyroidism, strict autoimmune

2.32

1.11

1.0

1.1

—

Sensorineural hearing loss

1.92

1.09

1.1

—

Other diseases of pleura

2.22

1.08

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.80

1.08

1.0

1.1

—

Dorsopathies

1.84

1.07

1.1

—

Coxarthrosis [arthrosis of hip](FG)

2.20

1.07

1.0

1.1

—

Obesity

1.93

1.07

1.0

1.1

—

2.35

1.07

1.4

1.0

—

Hallux valgus (acquired)

2.41

1.07

1.2

1.1

—

Diseases of the eye and adnexa

2.05

1.07

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.15

1.06

1.1

—

Parodontitis and operation codes

1.83

1.06

1.1

—

Acute upper respiratory infections

1.75

1.05

1.1

—

Other nutritional deficiencies

2.00

1.04

1.0

1.1

—

Diseases of liver

2.27

1.03

1.0

1.1

—

Urticaria and erythema

2.27

1.03

1.0

—

Alcohol use disorder, Swedish definition

1.94

1.03

1.0

1.1

—

Iron deficiency anaemia

2.25

1.02

1.0

—

Asthma/COPD (KELA code 203)

1.76

1.02

1.2

1.0

—

Acute sinusitis

2.04

1.01

1.1

—

Tonsillectomy and adenotomy

2.03

0.99

1.0

—

Coronary artery bypass grafting

0.00

0.99

0.0

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.80

0.99

1.0

1.1

—

Examination and observation for other reasons

2.03

0.98

1.0

—

Depression or dysthymia

1.87

0.98

1.1

—

Other enthesopathies

2.17

0.98

1.0

1.1

—

Disorders of vitreous body

1.96

0.97

1.0

1.1

—

Disorders of vitreous body and globe

1.95

0.97

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.83

0.96

1.0

1.1

—

Appendicitis, broad definition

1.80

0.96

1.1

—

1.79

0.95

1.0

1.1

—

Allergic conjunctivitis

1.91

0.95

1.1

—

Diseases of appendix

1.79

0.95

1.1

—

Conjunctivitis

1.85

0.94

1.1

—

Diseases of inner ear

1.90

0.94

1.1

—

Conductive and sensorineural hearing loss

1.81

0.94

1.1

—

Erysipelas

2.19

0.92

1.0

1.1

—

Chronic periodontitis, including avohilmo

1.74

0.92

1.1

—

Neurotic, stress-related and somatoform disorders

1.74

0.92

1.1

1.0

—

Parodontitis

1.73

0.91

1.1

—

Parodontitis or operation codes

1.73

0.91

1.1

—

Statin medication

1.87

0.89

1.1

1.0

—

Cystitis

1.85

0.89

1.0

1.1

—

Unspecified fall

2.05

0.88

1.0

1.1

—

External causes of morbidity and mortality

1.91

0.88

1.0

—

Benign neoplasms

1.89

0.88

1.0

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.05

0.87

1.2

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

2.04

0.87

1.0

1.1

—

Nutritional anaemias

2.01

0.87

1.0

—

Anxiety disorders

1.70

0.86

1.1

1.0

—

Disorders of the thyroid gland

1.70

0.85

1.0

1.1

—

Heart failure,strict

1.97

0.84

1.0

—

Injuries to the thorax

1.94

0.84

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.63

0.83

1.1

—

Constipation

1.71

0.81

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.71

0.80

1.0

1.1

—

Transient ischemic attack

1.84

0.79

1.0

1.1

—

Coxarthrosis

1.85

0.79

1.0

1.1

—

Appendectomy

1.67

0.79

1.1

1.0

—

Disorders of skin appendages

1.82

0.79

1.3

1.0

—

Noninfective enteritis and colitis

1.82

0.79

1.0

1.1

—

1.67

0.78

1.0

1.1

—

Acute appendicitis

1.72

0.77

1.1

—

Inflammatory diseases of female pelvic organs

1.81

0.77

1.0

1.1

—

Other external causes of accidental injury

1.73

0.77

1.0

—

Accidents

1.73

0.77

1.0

—

Peripheral artery disease

1.79

0.76

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.71

0.76

1.0

1.1

—

Abnormalities of heart beat

2.15

0.75

1.0

1.1

—

Pain in limb

1.72

0.75

1.0

1.1

—

Meniscus derangement

1.92

0.75

1.1

—

Benign neoplasm: Colon

2.13

0.75

1.0

1.1

—

Suppurative and unspecified otitis media

2.11

0.75

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.11

0.75

1.0

1.1

—

Diseases of the respiratory system

1.85

0.74

1.0

1.1

—

Irregular menses

2.03

0.73

1.0

1.1

—

Glaucoma

1.81

0.72

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

2.00

0.72

1.0

—

Diaphragmatic hernia

2.00

0.72

1.0

—

Delivery

2.03

0.72

1.0

—

Anxiety disorders, excluding more controls

1.61

0.72

1.1

—

Coxarthrosis, primary

1.74

0.70

1.0

1.1

—

Sciatica+with lumbago

1.90

0.70

1.0

1.1

—

Disorders of synovium and tendon

1.70

0.69

1.0

1.1

—

Dental caries 2 and operation codes

1.55

0.69

1.1

1.0

—

Noninflammatory disorders of female genital tract

1.94

0.69

1.0

—

Other and unspecified disorders of vitreous body

1.84

0.68

1.0

1.1

—

Disorders of vestibular function (Vertigo)

1.84

0.68

1.2

1.0

—

Injuries to the hip and thigh

1.83

0.67

1.2

1.0

—

Other heart diseases, wide

1.58

0.67

1.0

1.1

—

Medical abortion

1.65

0.67

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.74

0.65

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.60

0.65

1.0

1.1

—

Artificial joint operation, meniscal resection

1.59

0.64

1.2

1.0

—

Mood disorders, excluding more controls

1.59

0.63

1.1

—

Disorders of breast

1.72

0.63

1.2

1.0

—

Neoplasms

1.65

0.63

1.0

—

Unspecified haematuria

1.71

0.63

1.2

1.0

—

Gastro-oesophageal reflux disease

1.61

0.61

1.0

1.1

—

Chronic diseases of tonsils and adenoids

1.58

0.61

1.0

1.1

—

Myocardial infarction, without ST-elevation

1.65

0.60

1.2

1.0

—

Other specific joint derangements/joint disorders

1.53

0.59

1.0

1.1

—

Injuries to the ankle and foot

1.52

0.58

1.0

1.1

—

Arthrosis

1.52

0.58

1.0

1.1

—

Exposure to other specified factors

1.56

0.58

1.1

—

Dental caries 1 and operation codes

1.59

0.57

1.0

1.1

—

Pain in joint

1.65

0.56

1.0

1.1

—

Hypothyroidism, other/unspecified

1.57

0.56

1.0

1.1

—

Other disorders of ear

1.53

0.55

1.1

—

Dental caries 2, only avohilmo

1.54

0.55

1.1

1.0

—

Dental caries 2

1.54

0.55

1.1

1.0

—

Dental operations

1.62

0.55

1.0

1.1

—

Shoulder lesions

1.45

0.53

1.0

1.1

—

All-cause Heart Failure

1.54

0.53

1.0

—

Heart failure, strict

1.54

0.53

1.0

—

Persons encountering health services for examination and investigation

1.60

0.50

1.0

—

Diseases of the skin and subcutaneous tissue

1.47

0.49

1.2

1.0

—

Anxiety (asthma-related co-morbidities)

1.58

0.49

1.1

—

All anxiety disorders

1.56

0.49

1.1

—

Injuries to the shoulder and upper arm

1.50

0.49

1.0

1.1

—

Gonarthrosis

1.49

0.48

1.0

1.1

—

Soft tissue disorders

1.45

0.47

1.0

1.1

—

Bleeding

1.48

0.46

1.0

1.1

—

Benign neoplasms

1.46

0.46

1.0

—

Other arrhythmias

1.41

0.45

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.67

0.44

1.0

1.1

—

Mood [affective] disorders

1.41

0.44

1.1

1.0

—

Use of hypnotics and sedatives

1.39

0.44

1.0

1.1

—

Mood disorders

1.41

0.43

1.1

1.0

—

Coxarthrosis, primary, with hip surgery

1.63

0.43

1.0

1.1

—

Other menopausal disorders

0.00

0.43

0.0

1.0

—

Benzodiazepine use

1.42

0.43

1.1

—

Polyp of the female genital tract

0.00

0.42

0.0

1.0

—

Complications predominantly related to the puerperium

0.00

0.41

0.0

1.1

—

Exposure to unspecified factor

1.40

0.40

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.46

0.40

1.0

1.1

—

Parodontitis or/and operation codes

1.41

0.40

1.1

—

Ischaemic heart disease, wide definition

1.37

0.39

1.1

—

L02BG Aromatase inhibitors

0.00

0.39

0.0

1.1

—

Ischemic heart diseases

1.34

0.38

1.1

—

Benign neoplasm: Colon

1.40

0.38

1.0

1.1

—

Gonarthrosis,primary

1.32

0.38

1.1

—

Depression

1.38

0.37

1.1

1.0

—

Fall on same level involving ice and snow

1.43

0.35

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.42

0.35

1.2

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.38

0.35

1.0

—

Myocardial infarction

1.39

0.35

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.39

0.35

1.2

1.1

—

Carpal tunnel syndrome

1.39

0.35

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.36

0.34

1.2

1.1

—

Dental operations, only avohilmo

1.34

0.34

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.69

0.34

1.0

1.1

—

Malignant neoplasm of skin

1.33

0.33

1.2

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.32

0.33

1.0

1.1

—

Selective serotonin reuptake inhibitors

1.35

0.31

1.1

—

Major coronary heart disease event excluding revascularizations

1.27

0.30

1.1

—

Complications of procedures, not elsewhere classified

1.23

0.29

1.0

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.30

0.28

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

1.34

0.23

1.2

1.1

—

Gastrointestinal diseases

1.25

0.23

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.26

0.23

1.0

1.1

—

Acute appendicitis, no complications

1.22

0.22

1.0

—

Long labour

0.00

0.21

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

0.21

0.0

1.0

—

Impacted teeth

0.00

0.21

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Migraine without aura

0.00

0.21

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.1

—

Myocardial infarction, strict

1.18

0.21

1.2

1.1

—

Endometriosis ASRM stages 3,4

0.00

0.21

0.0

1.1

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.0

—

Use of memantine

0.00

0.21

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.21

0.0

1.0

—

Ganglion

0.00

0.20

0.0

1.1

—

Dental caries, including avohilmo

1.18

0.20

1.0

1.1

—

Dental caries 1

1.18

0.20

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.17

0.19

1.2

1.1

—

Other joint disorders

0.74

0.17

1.0

1.1

—

Dental caries 3 and operation codes

1.17

0.17

1.0

1.1

—

Dental caries 2 and operation codes, only avohilmo

1.18

0.17

1.1

1.0

—

Arthropathies

1.13

0.16

1.0

1.1

—

Hernia

1.17

0.15

1.0

1.1

—

Complications of labour and delivery

1.07

0.09

1.0

1.1

—

Dental pulpitis 2

1.07

0.09

1.0

1.1

—

Varicose veins

1.08

0.09

1.0

1.1

—

Pregnancy with abortive outcome

1.05

0.09

1.0

1.1

—

Inguinal hernia

1.05

0.09

1.0

—

Dental caries 1, only avohilmo

1.10

0.09

1.0

1.1

—

Dental caries 3, only avohilmo

1.05

0.08

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.86

0.07

1.0

1.1

—

Dental pulpitis 4, only avohilmo

1.10

0.05

1.1

—

Diseases of the ear and mastoid process

1.09

0.03

1.1

—

Dental pulpitis 1

1.04

0.00

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.04

0.00

1.1

—

Dental pulpitis 4

1.04

0.00

1.1

—

Dental pulpitis 1, only avohilmo

0.97

0.00

1.0

1.1

—

Artrosis, including avohilmo

0.98

0.00

1.0

1.1

—

Migraine without aura and triptan purchases

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Other disorders of the genitourinary system

0.00

0.0

1.0

—

Malignant neoplasm of bladder

0.00

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.0

1.0

—

Superficial injury of thorax

0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

0.0

1.0

—

Puerperal sepsis

0.00

0.0

1.1

—

Pain in thoracic spine

0.00

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

0.0

1.0

—

Dental caries 3

0.96

0.00

1.0

1.1

—

Other female pelvic inflammatory diseases

0.00

0.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.0

1.0

—

Chronic pancreatitis

0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

0.0

1.0

—

Perineal laceration during delivery

0.00

0.0

1.0

—

Inflammatory disease of uterus

0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

0.0

1.0

—

Suggestive for eosinophilic asthma

0.00

0.0

1.0

—

Early lumbar disc prolapse operation

0.00

0.0

1.0

—

Major coronary heart disease event

0.86

0.00

1.2

1.1

—

Benign neoplasm of meninges

0.00

0.0

1.0

—

Dental pulpitis 2, only avohilmo

1.02

0.00

1.0

1.1

—

Dental pulpitis 3, only avohilmo

0.00

0.0

1.0

—

Coeliac disease

0.00

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.0

1.1

—

Other/unspecified synovitis and tenosynovitis

0.00

0.0

1.0

—

Non-allergic asthma (mode), excluding more controls

0.00

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.0

—

Otitis media, unspecified

0.00

0.0

1.0

—

Non-allergic asthma (mode)

0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.0

1.0

—

Other embolism and thrombosis

0.00

0.0

1.0

—

Acute pharyngitis

0.00

0.0

1.1

—

Status post-ami

0.00

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

0.0

1.0

—

Crowding of teeth, including avohilmo

0.00

0.0

1.0

—

Coronary atherosclerosis

0.90

0.00

1.2

1.1

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.0

—

Dental pulpitis 3

0.00

0.0

1.0

—

Angina pectoris

0.96

0.00

1.0

1.1

—

Polycystic ovarian syndrome, broad definition

0.00

0.0

1.0

—

Other CVD

0.00

0.0

1.0

—

Valvular operations

0.00

0.0

1.0

—

Hypotension

0.00

0.0

1.0

—

Prolonged pregnancy

0.00

0.0

1.0

—

Migraine with aura and triptan purchases

0.00

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.0

—

Endometriosis of ovary

0.00

0.0

1.0

—

Allergic contact dermatitis

0.00

0.0

1.0

—

Premature rupture of membranes

0.00

0.0

1.0

—

Atrophic disorders of skin

0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

0.0

1.0

—

Presbycusis

0.00

0.0

1.0

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Acne

0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.0

1.0

—

Use of rivastigmine

0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

0.0

1.0

—

Injuries to the wrist and hand

0.92

0.00

1.1

1.0

—

Assault by bodily force

0.00

0.0

1.0

—

Foreign body on external eye

0.00

0.0

1.1

—

Injuries to the elbow and forearm

0.90

0.00

1.0

1.1

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS